共 241 条
[31]
Pietrantonio F(2016)Genetic heterogeneity in synchronous colorectal cancers impacts genotyping approaches and therapeutic strategies Genes Chromosom Cancer 55 268-1848
[32]
Petrelli F(2016)The influence of subclonal resistance mutations on targeted cancer therapy Nat Rev Clin Oncol 13 335-1729
[33]
Coinu A(2016)BRAF and NRAS locus specific variants have different outcomes on survival to colorectal cancer Clin Cancer Res. 23 2742-1964
[34]
Di Bartolomeo M(2015)Similar but different: distinct roles for KRAS and BRAF oncogenes in colorectal cancer development and therapy resistance Oncotarget. 6 20785-2092
[35]
Borgonovo K(2013)Low frequency KRAS mutations in colorectal cancer patients and the presence of multiple mutations in oncogenic drivers in non-small cell lung cancer patients Cancer Genet 206 330-1801
[36]
Maggi C(2013)The prognostic role of KRAS, BRAF, PIK3CA and PTEN in colorectal cancer Br J Cancer 108 2153-233
[37]
Sartore-Bianchi A(2016)Prognostic role of tumor PIK3CA mutation in colorectal cancer: a systematic review and meta-analysis Ann Oncol 27 1836-830
[38]
Martini M(2017)Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials Ann Oncol 28 1713-undefined
[39]
Molinari F(2006)Type, density, and location of immune cells within human colorectal tumors predict clinical outcome Science 313 1960-undefined
[40]
Veronese S(2018)Pembrolizumab plus chemotherapy in metastatic non-small-cell lung cancer N Engl J Med 378 2078-undefined